A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy

Дата публикации: 29-09-2026 10:00:05

In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Cancer biologists bring in the B-cell reinforcements for immunotherapy	0	8.93	17-09-2026
2	'Plug-and-play' CAR T technology adapts as cancer changes	0	8.18	22-09-2026
3	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
4	Want to lower your risk of dementia? It doesn't involve a blood test	0	8.75	15-09-2026
5	Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation	0	8.94	20-09-2026
6	New study finds a blood test may detect recurring breast cancer faster than a scan	0	8.6	31-08-2026
7	Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments	0	10.81	23-09-2026
8	Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy	0	6.96	28-09-2026
9	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
10	Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests	0	11.68	23-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.91. Источник: medicalxpress.com.